This assay is to provide M-NFS-60-based In Vivo Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
M-NFS-60
Target Cell Organism
Mouse
Target Cell Background
M-NFS-60 is a lymphoblast morphology that was isolated a mouse with myelogenous leukemia. This cell line was deposited by JF Weaver, A Creasey, and can be used in immune system disorder research.
Related Diseases
Myelogenous Leukemia
Research Area
Oncology
Assay Name
In Vivo Anti-Tumor Efficacy Assay
Short Description
M-NFS-60-cell based In Vivo Anti-Tumor Efficacy Assay
Assay Description
After positive anti-tumor efficacy data is concluded using in vitro assays, we can start to initiate in vivo anti-tumor efficacy studies. Creative Biolabs offers a wide variety of PDX or CDX models to facilitate the efficacy studies. This assy will be used to evaluate the anti-tumor efficacy of your therapeutic candidates, such as small molecules, antibodies, CARTs or other biologics. Detailed group set up and other plans will be discussed according to your specific requirements.